Haematology Flashcards

1
Q
Causes of the following blood film findings -
Burr cells
Target cells
Tear drop
Pencil poikilocytes
Heinz bodies
Howell Jolly bodies
Reticulocytosis
Schistocytes
Sideroblasts
Smudge cells
Spherocytes
A
  • Burr cells - uraemia
  • Target cells – iron deficiency anaemia, post-splenectomy, sickle cell
  • Tear drop poikilocytes - myelofibrosis
  • Pencil poikilocytes: iron deficiency
  • Heinz bodies – G6PD, alpha thalassaemia
  • Howell-Jolly bodies – post-splenectomy, severe anaemia
  • High number of reticulocytes – haemolytic anaemia
  • Schistocytes – HUS, DIC, TTP, metallic heart valves, haemolytic anaemia
  • Sideroblasts – myelodysplastic syndrome
  • Smudge cells – chronic lymphocytic leukaemia
  • Spherocytes – autoimmune haemolytic anaemia, hereditary spherocytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of microcytic anaemia

A
TAILS
Thalassaemia
Anaemia of chronic disease
Iron deficiency
Lead poisoning
Sideroblastic anaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of normocytic anaemia

A

Acute blood loss
Anaemia of chronic disease (eg. renal failure)
Aplastic anaemia
Haemolytic anaemia
Hypothyroidism (can be normocytic or macrocytic)
Pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of megaloblastic macrocytic anaemia (megaloblastic = impaired DNA synthesis)

A

Folate deficiency
B12 deficiency
Pernicious anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of normoblastic macrocytic anaemia

A
Alcohol
Reticulocytosis
Hypothyroidism
Liver disease
Drugs (eg. azathioprine)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Specific signs and symptoms caused by iron deficiency anaemia

A

Koilonychia – spoon shaped nails
Angular chelitis/stomatitis – inflammation of the corners of the mouth
Atrophic glossitis – smooth tongue due to atrophy of the papillae
Brittle hair and nails
Pica – dietary cravings to abnormal things (eg. dirt)
Hair loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Investigations for anaemia

A
FBC: haemoglobin, MCV
B12
Folate
Ferritin
Blood film
Further Ix: OGD or colonoscopy to investigate for a GI cause of iron deficiency anaemia, bone marrow biopsy if cause is unclear
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of iron deficiency anaemia

A

Blood loss (eg. menorrhagia, oesophagitis, gastritis, GI cancer, IBD)
Dietary insufficiency
Increased requirements during pregnancy
Poor iron absorption: coeliac/Crohns cause inflamm of duodenum/jejunum which is where iron is absorbed. Stomach acid is required to keep iron in the ferrous form, reduced stomach acid changes iron into insoluble ferric form. Drugs which reduce stomach acid (eg. PPI) reduce iron absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Iron tests

A

Iron travels in blood as ferric irons (Fe3+), bound to a carrier protein called transferrin
Ferritin – reliable marker. Low in iron deficiency anaemia, high in inflammation/ infection/ cancer (released from cells)
Serum iron - unreliable to use on its own as it varies throughout the day
Total iron binding capacity (TIBC) is the total amount of space on a transferrin molecule for iron to bind to
TIBC – a marker for how much transferrin is in the blood. Increases in iron deficiency and decreases in iron overload
Transferrin saturation (%) = serum iron / TIBC
Transferrin saturation gives a good indication of the total iron in the body (30% is normal in adults, will be reduced in iron deficiency and raised in iron overload)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management of iron deficiency anaemia

A

Oral ferrous sulphate TDS – slowly corrects iron deficiency (Hb rises by 10g/L every week). Causes constipation and black stools. Unsuitable in malabsorption.
Iron infusions – small risk of anaphylaxis but quickly corrects iron deficiency. Avoid during sepsis as it worsens sepsis.
Blood transfusion – immediately corrects the anaemia but carries risks
OGD and colonoscopy required for new iron deficiencies in adults without clear underlying cause to look for cancer of GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of B12 deficiency anaemia

A
Insufficient dietary intake of B12 (animal products)
Pernicious anaemia (autoantibodies against parietal cells or intrinsic factor -> intrinsic factor deficiency -> unable to absorb vit B12 in ileum)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Clinical features of B12 deficiency anaemia

A
Peripheral neuropathy (numbness, paraesthesia)
Loss of vibration sense or proprioception
Visual changes
Mood or cognitive changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Investigations fo pernicious anaemia

A

FBC, B12 levels, Intrinsic factor antibody (first line for pernicious anaemia), gastric parietal cell antibody (less helpful)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of pernicious anaemia/ B12 deficiency

A

Dietary deficiency can be treated with oral replacement with cyanocobalamin
Pernicious anaemia can be treated with IM B12 (hydroxycobalamin)
If there is also folate deficiency, B12 deficiency must be treated before folate deficiency otherwise it can lead to subacute combined degeneration of the cord

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Causes of haemolytic anaemia

A

Inherited: hereditary spherocytosis, hereditary elliptocytosis, thalassaemia, sickle cell disease, G6PD deficiency
Acquired: autoimmune haemolytic anaemia, alloimmune haemolytic anaemia, paroxysmal nocturnal haemoglobinuria, microangiopatic haemolytic anaemia, prosthetic valve related haemolysis, drugs (methyldopa, penicillin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Features of haemolytic anaemia

A

Anaemia, due to reduction of circulating RBC: tiredness, SOB, headache, dizziness, palpitations, pallor
Splenomegaly as the spleen becomes filled with destroyed RBCs
Jaundice as bilirubin is released during RBC destruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Intravascular vs extravascular haemolytic anaemia

A

Intrinsic – RBC destruction within the blood vessels due to abnormal RBCs
Extrinsic – RBC destroyed in spleen/ liver/ BM/ lymph

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Investigations for haemolytic anaemia

A

FBC – normocytic anaemia, high reticulocytes, MCHC increased in autoimmune haemolytic anaemia and spherocytosis
LFTs – bilirubin high
LDH – high
Haptoglobin – low in intravascular haemolysis (haptoglobin binds to free Hb, so if there is increased Hb release from RBCs there will be more binding of haptoglobin to Hb and therefore less haptoglobin in the circulation)
Blood film – schistocytes (fragments of RBCs), spherocytes, reticulocytes
Direct Coombs test – positive in autoimmune haemolytic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Hereditary spherocytosis - 
Inheritance
Presentation
Ix
Mx
A

Autosomal dominant -> causes sphere-shaped RBCs which are fragile and break down when passing through the spleen
Jaundice, gallstones, splenomegaly, aplastic crisis in the presence of parvovirus
Ix: family history, spherocytes on blood film, raised MCHC, raised reticulocytes
Mx: folate supplementation and splenectomy, cholecystectomy may be required if gallstones are troublesome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
G6PD deficiency
inheritance
crisis triggers
presentation
investigations
Mx
A

X-linked recessive
Crises triggered by infections, medications (primaquine, ciprofloxacin, sulphonylureas, sulfasalazine), broad beans
Jaundice (usually neonatal), gallstones, anaemia, splenomegaly
Ix: Heinz bodies on blood film, G6PD enzyme assay
Mx: avoid triggers, and transfuse if severe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Warm vs cold autoimmune haemolytic anaemia

A

Warm type AIHA – more common, haemolysis occurs at body temp, usually idiopathic, usually extravascular. Examples: SLE, lymphoma, CLL, methyldopa

Cold type AIHA – haemolysis at 4 degrees, haemolysis usually intravascular, often causes raynauds and acrocynaosis. Often secondary to lymphoma, leukaemia, SLE, mycoplasma, EBV, CMV and HIV. Responds less well to steorids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Management of autoimmune haemolytic anaemia

A

Blood transfusions
Prednisolone
Rituximab
Splenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q
Alpha thalassaemia
inheritance
defect
presentation
diagnosis
management
A

Autosomal recessive
Defects in alpha globin chains
If all 4 alpha globin alleles are affected -> death in utero
Diagnosis: FBC (microcytic anaemia), haemoglobin electrophoresis, DNA testing
Management: monitor FBC, monitor complications, blood transfusions (risk of iron overload), splenectomy, BM transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q
Beta thalassaemia
inheritance
defect
presentation
diagnosis
management
A

Autosomal recessive
Defects in beta globin chains (minor, intermedia or major depending on the type)
Beta thalassaemia major causes failure to thrive in first year of life, severe microcytic anaemia, splenomegaly and bone deformities (eg. pronounced forehead due to enlarging BM in order to produce more RBCs)
Diagnosis: FBC (microcytic anaemia), haemoglobin electrophoresis, DNA testing
Management: regular transfusions (risk of iron overload), iron chelation, splenectomy, BM transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Sickle cell disease - pathophysiology and relation to malaria

A

Autosomal recessive mutation of beta globin gene -> Haemoglobin S
One copy of mutated gene -> sickle-cell trait (asymptomatic)
Two copies of mutated gene -> sickle-cell disease
Sickle RBCs are fragile and easily destroyed -> haemolytic anaemia
Prone to sickle cell crises
Patients with a sickle cell trait aren’t affected by malaria as much as other people, so survive and pass on the gene, therefore there is a selective advantage to having sickle cell in areas of malaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Complications of sickle cell disease

A
Anaemia
Increased risk of infection
Stroke
Avascular necrosis
Pulmonary hypertension
Painful persistent erection
CKD
Sickle cell crises
Acute chest syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Management of sickle cell disease

A

Avoid dehydration and other triggers of crises
Ensure vaccines are up to date
Abx prophylaxis with pen V
Hydroxycarbamide stimulates production of foetal haemoglobin which does not leas to RBC sickling (protective effect against sickle cell crises)
Blood transfusions for severe anaemia
Bone marrow transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Types of sickle cell crises

A

Painful crisis – thrombi in capillaries -> distal ischaemia. Associated with dehydration and raised haematocrit

Splenic sequestration crisis – RBCs block blood flow within spleen-> acutely large painful spleen. Pooling of blood in spleen -> severe anaemia and hypovolaemic shock. Emergency -> transfusions, fluid, splenectomy if recurrent

Aplastic crisis – loss of RBC production due to parvovirus B19 -> significant anaemia

Acute chest syndrome – fever or resp symptoms with new infiltrates on CXR. Either due to infection or non-infective causes. Emergency -> supportive Mx, abx/antivirals, transfusions, incentive spirometry, NIV or intubation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Triggers of sickle cell crises

A

Infection, dehydration, cold, significant life events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Management of sickle cell crises

A

Hospital admission, treat any infection, do a septic screen, keep warm, oxygen if required, keep hydrated with IV fluids, appropriate analgesia, blood transfusion if required, treat underlying cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Causes of neutropenia

A

Viral infections
Drugs: chemo, cytotoxics, carbimazole, sulphonamides
Severe sepsis
Neutrophil antibodies (SLE, haemolytic anaemia) -> increased destruction
Bone marrow failure (reduced production)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Causes of neutrophilia

A
Bacterial infections
Inflammation
Myeloproliferative disorders
Drugs (eg. steroids)
Disseminated malignancy
Stress (eg. trauma, burns, haemorrhage, seizure)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Causes of lymphopenia

A

Steroid therapy (SLE, uraemia, HIV, marrow infiltration, chemo, radiotherapy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Causes of lymphocytosis

A

Acute viral illness
Chronic infection (TB, hepatitis, syphilis)
Leukaemia (esp chronic lymphocytic leukaemia)
Lymphoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q
Haemophilia A
Inheritance
Deficiency
Presentation
Ix
Mx
Complication of treatment
A

Factor VIII deficiency

X-linked recessive

Usually presents in neonates or early childhood -> intracranial haemorrhage, haematomas, cord bleeding

Bleeding into joints -> crippling arthropathy
Bleeding into muscles-> haematomas (neuropathy, compartment syndrome)

Ix: Increased APTT, reduced factor VIII assay

Mx: Avoid NSAIDs and IM injections. For minor bleeds can give pressure and elevation of body part, plus desmopressin to increase factor VIII levels. If more severe bleeding give recombinant factor VIII. Genetic counselling

Complications: some patients develop antibodies to factor VIII treatment making it ineffective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q
Haemophilia B
deficiency
inheritance
presentation
Ix
Mx
A

Factor IX deficiency
X linked recessive
Presentation same as haemophilia A: haemorrhage (spontaneous or a result of minor trauma) -> into muscle (nerve compression, compartment syndrome), or into joints (crippling arthropathy). Often presents as neonate (ICH, bleeding into cord, haematomas)
Ix: raised APTT, reduced factor IX assay
Mx: recombinant factor IX. Avoid IM injections and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Immune thrombocytopenia

A

Autoantibodies against platelets
Acute or chronic
Acute - usually in children, 2wks after infection, self-limiting purpura
Chronic – usually in women, bleeding, purpura, epistaxis, menorrhagia
No splenomegaly
Ix: Increased megakaryocytes in BM, antiplatelet autoantibodies
Mx: aim to keep platelets >30. prednisolone if symptomatic or platelets <20, IV immunoglobulin (temp raises platelet levels), rituximab, splenectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Abnormal coagulation (effect on APTT, PT, bleeding time)
Haemophilia
vWF disease
Vit K deficiency

A

Haemophilia: APTT increased, PT normal, bleeding time normal

Von Willebrand disease: APTT increased, PT normal, bleeding time increased

Vit K deficiency: APTT increased, PT increased, bleeding time normal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q
Abnormal coagulation (factors affected)
Heparin
Warfarin
DIC
Liver disease
A

Heparin: prevents activation factors 2, 9, 10, 11

Warfarin: affects synthesis of factors 2, 7, 9, 10

DIC: factors 1, 2, 5, 8, 11

Liver disease: factors 1, 2, 5, 7, 9, 10, 11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is APTT and what does it test
What is normal APTT
What causes prolonged APTT

A

Partial thromboplastin time
Tests clotting factors involved in the intrinsic and common pathways of coag cascade: fibrinogen (I), thrombin (II), X, XI, XII, co-factors V and VIII

A normal blood sample should clot in 30-40s

Prolonged APTT: deficiency in the tested factors, DIC, heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q
What is PT
What does it test
What is a normal PT
How INR works
Causes of prolonged PT
A

Prothrombin time, tests extrinsic pathway
Factors: fibrinogen (I), thrombin (II), VII, IX, X

Normal PT is 11-13s

PT measures factors II, VII, IX, X which are all vit K dependent so will be reduced when taking warfarin -> can therefore be used to monitor warfarin levels. Calculates as patient PT compared to PT or population -> INR value

Prolonged PT: severe liver disease, vit K deficiency, warfarin, DIC, sepsis

42
Q

Causes of thrombocytopenia

A

Low production: sepsis, B12 or folate deficiency, liver failure, leukaemia, myelodysplastic syndrome

High destruction: alcohol, ITP, TTP, HIT, HUS, drugs (sodium valproate, methotrexate, isotretinoin, antihistamines, PPI)

43
Q

Thrombotic thrombocytopenic purpura

what happens
management

A

Either genetic mutation or autoimmune

Tiny blood clots throughout the small vessels of the body using up platelets and causing thrombocytopenia, bleeding under the skin and other systemic issues

Due to a deficiency in the protein responsible for inactivating vWF -> causes overactivity of vWF, increased platelet adhesion and clot formation

The clots in the small vessels break up RBCs -> haemolytic anaemia

Mx: plasma exchange, steroids, rituximab

44
Q

Von Willebrand disease

  • inheritance
  • typical presentation
  • three types
  • ix
  • mx
A

Most common inherited cause of abnormal bleeding
Most are autosomal dominant

Epistaxis, menorrhagia, bleeding gums

Three types:

  1. partial reduction in vWF (most common)
  2. abnormal form of vWF
  3. total lack of vWF (autosomal recessive)

Ix: prolonged bleeding time, APTT may be prolonged, factor VIII may be reduced

Mx: tranexamic acid for mild bleeding, desmopressin raises vWF levels, factor VIII concentrate

45
Q

Presentation and management of acute haemolytic reaction

A

Presentation: agitation, rapid onset fever, hypotension, flushing, abdo/chest pain, oozing venepuncture sites, DIC

Mx: stop transfusion, tell blood bank and haematologist, sent the unit of blood + UE + FBC + clotting + cultures + urine to labs, give IV saline, treat DIC

46
Q

Presentation and management of anaphylaxis as a response to blood transfusion

A

Presentation: bronchospasm, cyanosis, hypotension, soft tissue swelling

Mx: stop transfusion, maintain airway, give oxygen, contact anaesthetist, give IM adrenaline, chlorphenamine, hydrocortisone

47
Q

Presentation and management of TRALI

A

Presentation: dyspnoea, cough, CXR shows ‘white out’

Mx: stop transfusion, give 100% O2, treat as ARDS (resp and circulatory support)

48
Q

Presentation and Mx or non-haemolytic febrile transfusion reaction

A

Presentation: shivering and fever usually half hour/1 hour after starting transfusion

Mx: slow or stop the transfusion, give an antipyretic (paracetamol), monitor closely, if recurrent use WBC filter

49
Q

Allergic reactions to blood transfusion presentation and management

A

Presentation: urticaria, itch

Mx: slow or stop transfusion, chlorphenamine 10mg slow IV/IM, observe closely, restart transfusion if symptoms resolve

50
Q

Fluid overload transfusion reaction presentation and management

A

Presentation: dyspnoea, hypoxia, tachycardia, raised JVP, basal crepitations

Mx: slow or stop transfusion, give O2 and diuretic, consider CVP line

51
Q

Management of high INR

A

Major bleed: Stop warfarin, give IV vit K 5mg, prothrombin complex concentrate (or FFP)

INR >8, minor bleed: stop warfarin, give IV vit K 1-3mg, restart warfarin when INR <5

INR >8, no bleed: stop warfarin, give vit K 1-5mg PO, restart when INR<5

INR 5-8, minor bleed: stop warfarin, give IV vit K 1-3mg, restart when INR<5

INR 5-8, no bleed: withhold 1 or 2 doses, reduce subsequent maintenance dose

52
Q

Factors that may potentiate warfarin

A

liver disease, P450 inhibitors, cranberry juice, drugs which displace warfarin from albumin (NSAIDs), inhibits platelet function (NSAIDs)

53
Q

Acute lymphoblastic leukaemia

  • epidemiology
  • features
  • Ix
A

Affects children, 2-5years of age, boys>girls
Usually affects B lymphoblasts
Associated with Down’s syndrome

Features:
BM failure (anaemia, neutropenia, thrombocytopenia) -> lethargy, pallor, frequent severe infections, easy bruising, patechiae
Bone pain (secondary to BM infiltration)
Splenomegaly
Hepatomegaly
Fever
Testicular swelling

Ix: FBC, blood film, bone marrow biopsy
Consider immunophenotyping, cytogenetics, lymph node biopsy, LP, CT, CXR

54
Q

ALL poor prognostic factors

A
<2 or >10
WBC >20 at diagnosis
T or B cell surface markers
Non-Caucasian
Male
55
Q

Age presentations of ALL, CLL, CML, AML

A

ALL: <5
CLL: >55
CML: >65
AML: >75

56
Q

Differential diagnoses of patechiae (non-blanching rash caused by bleeding under the skin)

A
Leukaemia
Meningococcal septicaemia
Vasculitis
HSP
ITP
NAI
57
Q

Investigating leukaemia

A

FBC with differential
Blood film
Lactate dehydrogenase (raised, but not specific)
BM biopsy: aspiration looks at cells in the liquid bone marrow, BM trephine looks at the cells and structure of the solid BM

58
Q

ALL investigations and management

A

Ix:
FBC with differential shows high WCC, anaemia, thrombocytopenia, neutropenia
Blood film shows blast cells
CXR and CT may show mediastinal and abdo lymphadenopathy
LP to look for CNS involvement

Mx:
Supportive: blood/platelet transfusions, IV fluids, allopurinol, hickman line

May have BMT

Chemo: 3 phases
Induction of remission – vincristine, steroids (dex) and L-asparaginase
Intensification/ consolidation – add new chemo agents
Maintenance (for 2 yrs) – immunosuppressants and more chemo

59
Q

Chronic lymphocytic leukaemia

  • how common
  • what is it
  • who does it affect
  • presentation
  • transformation
  • ix
  • mx
A

Commonest leukaemia

Over proliferation of a single type of small well differentiated lymphocyte (usually B lymphocytes)

Usually affects adults >55

Often asymptomatic but can present with infections, anaemia, bleeding, weight loss, warm AIHA, ITP, sweating

Can transform into high-grade lymphoma (Richter’s transformation)

Ix: FBC with differential shows lymphocytosis, anaemia, neutropenia, thrombocytopenia, autoimmune haemolysis (later)
Blood film: smear or smudge cells
Immunophenotyping

Mx:
Watchful waiting is asymptomatic
If symptomatic -> combination chemo regimen (ibrutinib, steroids, cyclophosomide, rituximab, etc)

60
Q

Chronic myeloid leukaemia

  • cause
  • presentation
  • ix
  • mx
A

Philadelphia chromosome (9:22 translocation) -> BCR-ABL gene

Presentation: 60yrs+, anaemia (lethargy), may have hyperviscosity due to raised WCC, weight loss, sweating, splenomegaly, thrombocytosis, reduced leukocyte ALP, blast transformation may occur (AML, ALL)

Ix: significantly raised WCC (high neutrophils, monocytes, basophils, eosinophils), anaemia, platelets variable, high urate, high B12
BM is hypercellular
Cytogenetic analysis of blood or BM for philadelphia chromosome

Management: imatinib first line (tyrosine kinase inhibitor), hydroxyurea, interferon-alpha, allogeneic BMT

61
Q

Acute myeloid leukaemia

  • epidemiology and causes
  • presentation
  • ix
  • mx
A

Commonest acute leukaemia in adults
Middle age onwards
May be a result of transformation from a myeloproliferative disorder

Progresses rapidly
BM failure (anaemia, infection, bleeding), DIC, hepatomegaly, splenomegaly, gum hypertrophy, skin involvement

Ix: WCC raised (or normal, or low), blast cells in BM biopsy, immunophenotyping, cytogenetic analysis, blood film shows blast cells (auer rods differentiated ALL from AML)

Mx: intensive chemotherapy or allogeneic bone marrow transplant, with supportive care

62
Q

What are the differences in clinical features and lab results, between Hodgkin’s and Non-Hodgkin’s lymphoma?

A

Hodgkin’s has characteristic Reed-Sternberg cells

Hodgkins has alcohol-induced lymph node pain

Hodgkins get B symptoms earlier on compared to Non-Hodgkins

Non-Hodgkins are more likely to get extra-nodal disease compared to Hodgkins

63
Q

Hodgkins lymphoma risk factors and age group

A
Bimodal age distribution (20s and 60s)
HIV
Epstein-Barr virus
Autoimmune conditions (RA, sarcoidosis)
Family history
64
Q

Signs and symptoms of Hodgkin’s lymphoma

A

Enlarged, painless, asymmetrical, non-tender rubbery superficial lymph node

B symptoms (poor prognosis): weight loss, night sweats, fever

Alcohol-induced lymph node pain

Other systemic features: pruritus, cough, fatigue, SOB, abdo pain, recurrent infection

Signs: lymphadenopathy, cachexia, anaemia, hepatosplenomegy

65
Q

Investigations for Hodgkin’s lymphoma

A

Lymph node excision biopsy is diagnostic test: Reed-sternberg cells (large B cells with multiple nuclei)

Bloods: FBC (normocytic anaemia, eosinophilia), raised LDH, blood film, raised ESR, LFT, urate, calcium

Imaging: CXR, CT/PET chest abdo pelvis

CT CAP used for staging

66
Q

Staging for lymphomas

A

Ann-Arbor staging

  1. Confined to one region of lymph nodes
  2. More than one region but same side of diaphragm
  3. More than one region of lymph nodes, both sides of diaphragm
  4. Extra-lymphatic infiltration (lungs, liver, etc)

Each stage is either A (no systemic symptoms other than pruritus) or B (B symptom involvement)

67
Q

Management of Hodgkin’s lymphoma

A

Combination chemoradiotherapy

68
Q

Subtypes of Hodgkin’s lymphoma

A

Nodular sclerosing Hodgkin lymphoma (most common)
Mixed-cellularity Hodgkin lymphoma
Lymphocyte-depleted Hodgkin lymphoma (worst prognosis)
Lymphocyte-rich classical Hodgkin lymphoma (best prognosis)

69
Q

Poor prognostic factors of Hodgkin lymphoma

A

Age >45, stage IV disease, low Hb, low lymphocyte (lymphocyte depleted subtype), male, low albumin, high WCC

70
Q

What is lymphoma

A

Malignant proliferation of lymphocytes which accumulate in lymph nodes or other organs

71
Q

Non-Hodgkin Lymphoma

  • incidence
  • risk factors
A

More common than Hodgkin’s lymphoma
Typically affects the elderly

Risk factors: elderly, caucasian, Hx of EBV, FHx, chemical agents, Hx of chemo/radiotherapy, immunodeficiency (transplant, HIV, DM), autoimmune disease (SLE, sjögrens, coeliac)

72
Q

Presentation of Non-Hodgkin’s lymphoma

A

Painless, non-tender, rubbery, asymmetrical lymphadenopathy

B symptoms: fever, weight loss, night swears, lethargy

Extra-nodal disease: gastric (dyspepsia, dysphagia, weight loss, abdo pain), bone marrow (pancytopenia, bone pain), lungs, skin, CNS (nerve palsies)

Signs: weight loss, lymphadenopathy, palpable abdo mass (hepatomegaly, splenomegaly, lymph nodes), testicular mass, fever

73
Q

Investigations for Non-Hodgkin’s lymphoma

A

Excisional node biopsy is diagnostic investigation of choice

CT CAP for staging

FBC and blood film (normocytic anaemia)
ESR (raised = poor prognosis)
LDH (raised)
LFTs (?liver mets)
PET CT or BM biopsy (?bone involvement)
LP (if neuro symptoms)
HIV test (risk factor for NHL)
74
Q

Management of Non-hodgkin lymphoma

A
Depends on subtype
Watchful waiting if low grade
High grade:
Chemotherapy
Monoclonal antibodies (rituximab)
Radiotherapy
Stem cell transplantation

Flu and pneumococcal vaccinations
If neutropenia -> prophylactic abx

75
Q

Subtypes of Non-Hodgkin lymphoma

A

B cell low grade: follicular, waldenström’s macroglobulinaemia

B cell high grade: diffuse large B cell (most common), Burkitts lymphoma, mantle cell lymphoma

T cell - rare

Chronic lymphocytic leukaemia can undergo Richter’s transformation into a high grade non-Hodgkin lymphoma

76
Q

Burkitt’s lymphoma

  • what is it
  • two forms
  • associated conditions
  • microscopic finding
  • management
A

High-grade B cell non-Hodgkins lymphoma

Two forms: endemic (typically africa, involving maxilla/ mandible), or sporadic (abdo tumours most common, in HIV)

Associated with EBV, malaria and HIV

Microscopic finding: starry sky appearance

Management: chemotherapy and rasburicase due to high risk of tumour lysis syndrome

77
Q

Multiple myeloma features

A

CRAABBI

Calcium raised (increased osteoclast activity -> constipation, nausea, anorexia, confusion)

Renal damage (due to immunoglobulin deposition -> dehydration, thirst)

Anaemia (BM crowding suppresses erythropoiesis -> fatigue and pallor)

Amyloidosis

Bleeding (BM crowding -> thrombocytopenia -> bleeding and bruising). May also get hyperviscosity.

Bone pain/fragility fractures (BM infiltration and osteoclast overactivity -> lytic bone lesions)

Infection (reduction in proliferation of normal immunoglobulins)

78
Q

What is multiple myeloma and what is it’s incidence

A

Haematological malignant proliferation of plasma cells
Usually produces a monoclonal immunoglobulin (eg. IgA, IgG), a monoclonal light chain, or both (paraproteins)

Common in elderly (median age at presentation is 70)

Risk factors: older age, male, black african ethnicity, FHx, obesity

79
Q

Investigations for myeloma

A

Consider myeloma in anyone >60 with persistent bone pain (esp back pain), or unexplained fractures

FBC (pancytopenia), calcium (raised), ESR (raised), U+E (high urea and creatinine due to kidney injury), plasma viscosity (raised)

Urgent serum protein electrophoresis shows monoclonal Ig protein band

Bone marrow aspiration and trephine biopsy (raised plasma cells)

Urine Bence-Jones protein test

Skeletal survery shows lytic ‘punched-out’ lesions

80
Q

Management of myeloma

A

Chronic relapsing and remitting malignancy so management aims to control symptoms, reduce complications and prolong survival

In young, healthy patients: stem cell transplant and rigorous chemotherapy regimes, and 3-monthly monitoring

For others: chemo

81
Q

Complications of multiple myeloma treatment and management of complications

A

Pain: analgesia
Pathological fractures: zolendronic acid (bisphosphonate)
Infection: annual flu vaccines and immunoglobulin replacement therapy
VTE prophylaxis
Fatigue

82
Q

Types of myeloproliferative disorders

A

Primary myelofibrosis
Polycythaemia vera
Essential thrombocythaemia, Chronic myeloid leukaemia

83
Q

Primary myelofibrosis

  • what is it
  • gene mutations
  • typical presentation
  • investigations
  • management
  • transformation
A

Hyperplasia of abnormal megakaryocytes -> platelet derived growth factor release -> BM fibrosis and haematopoiesis in liver and spleen

50% have JAK2 mutation

Presentation: elderly patient with anaemia symptoms
Massive splenomegaly
Hypermetabolic symptoms (weight loss, night sweats, fever, etc)

Investigations:
FBC (anaemia, high WCC, high PLT in early disease)
Blood film (tear-drop poikilocytes)
BM biopsy unobtainable (‘dry tap’) as it has turned into scar tissue- trephine biopsy needed
High urate and high LDH (increased cell turnover)

Mx: allogeneic stem cell transplant, chemo, splenectomy, supportive

May transform into acute myeloid leukaemia

84
Q

Polycythaemia vera

  • what is it
  • genetic mutation
  • age
  • features
A

Myeloproliferative disorder caused by clonal proliferation of marrow stem cell -. increase in RBC volume, often accompanied by overproduction of neutrophils and platelets

JAK2 mutation in majority

Typically in 50yrs+

Features: hyperviscosity (headache, dizziness, tinnitus, visual disturbance, stroke, ischaemia, VTE), pruritus after a hot bath, splenomegaly, haemorrhage (due to abnormal platelets), plethora, HTN

85
Q

Polycythaemia vera

  • investigations
  • management
  • transformation
A
Ix:
FBC and blood film (raised Hb, haematocrit, neutrophils, basophils, platelets)
JAK2 mutation
Serum ferritin
U+Es, LFTs
Low ESR
BM biopsy shows hypercellularity with erythroid hyperplasia
Reduced serum erythropoietin

Normal haematocrit: 0.48 (female), 0.52 (male)
Management:
Aspirin 75mg OD
Venesection (first line)
Hydroxyurea (may cause secondary leukaemia)
Phosphorous-32 chemotherapy

May transform to acute myeloid leukaemia or myelofibrosis

86
Q

Essential thrombocythaemia

  • what is it
  • features
  • ix
  • mx
A

Clonal proliferation of megakaryocytes -> high platelets with abnormal function -> bleeding, arterial/venous thrombosis, microvascular occlusions

Ix: platelet count&raquo_space;600, JAK2 in 50%

Mx: aspirin 75mg OD, hydroxyurea if high risk

87
Q

Causes of thrombocytosis

A

Reactive thrombocytosis (raised platelets in response to infection, surgery, iron deficiency anaemia)

Malignancy

Essential thrombocythaemia

Hyposplenism

88
Q

Causes of polycythaemia

A

Relative polycythaemia (reduce plasma volume, normal RBC mass - acute due to dehydration or chronic due to obesity and HTN)

Absolute polycythaemia:
Primary: polycythaemia vera
Secondary: hypoxia, chronic lung disease, cyanotic heart disease, increased erythropoietin

89
Q

Types of thrombophilia

A
Antiphospholipid syndrome
Antithrombin deficiency
Protein C or S deficiency
Factor V leiden
etc
90
Q

Antiphospholipid syndrome

  • Features
  • Diagnosis
  • Mx
  • Associated condition
A

Features: CLOTS
Coagulation defect, Livedo reticularis, Obstetric (recurrent miscarriage), Thrombocytopenia

Dx: persistent antiphospholipid antibodies with clinical features
Paradoxical rise in APTT

Mx: anticoagulation, and advice re pregnancy

Associated with SLE

91
Q

Aplastic anaemia

  • peak incidence
  • features
  • causes
  • diagnosis
  • management
A

Peak incidence = 30 years

Features: 
Normochromic, normocytic anaemia
Leukopenia
Thrombocytopenia
(pancytopenia)
Hypoplastic bone marrow, majority fat cells within BM
Raised erythropoietin
Causes:
Idiopathic
Congenital (Fanconi anaemia)
Drugs (cytotoxics, chloramphenicol, sulphonamides, phenytoin)
Toxins (benzene)
Infections (parvovirus, hepatitis)
Radiation

Often diagnosed by excluding other marrow diseases

Mx: stop causative agent, supportive treatment (transfusions), BM transplant, immunosuppressive agents

92
Q

Disseminated Intravascular Coagulation

  • what happens
  • causes
  • features
  • diagnosis
  • management
A

Dysregulation between coagulation and fibrinolysis, release of tisue factor -> widespread clotting with resultant bleeding

Causes: sepsis, trauma, obstetric complications (amniotic fluid embolism, haemolysis, HELLP), malignancy

Features:
Haemorrhages (petechiae, ecchymoses, epistaxis, bleeding from mouth, vagina, urinary and GI tract, pituitary gland, liver, adrenals and brain)
Signs of widespread thrombi (digital gangrene, ARDS, stroke, renal failure)
Mild hypotension

Diagnosis: low platelets, prolonged APTT, prolonged PT, prolonged bleeding time, fibrin degradation products are often raised
Blood film shows schistocytes due to microangiopathic haemolytic anaemia

Management: remove cause (eg. deliver baby, stop drug), transfusion of blood, FFP, and platelet concentrations

93
Q

Factor V leiden

  • incidence
  • mutation
  • VTE risk
A

Commonest inherited thrombophilia

Mutation in the factor V leiden protein -> activated factor V (clotting factor) is inactivated 10 times more slowly than usual due to activated protein C resistance

Heterozygotes have a 4-5x increased risk of VTE, homozygotes have a 10x increased risk

94
Q

Two types of BM transplant

  • processes
  • indications
  • complications
A

Autologous: patients own stem cells. Patient is primed with G-CSF and chemo, patient’s own stem cells are harvested, pt is given high dose chemo, stem cells are reintroduced. Risk of reinfusing malignant cells. Indicated in relapsed Hodgkins, or in young patients with non-hodgkins or myeloma

Allogeneic: uses HLA-matched donor’s stem cells. Patient is given high dose chemo then infused with donor stem cells.

Complications of allogeneic: Infection due to immunosuppressive agents post transplant, cytomegalovirus (from donor), Graft vs. host disease

95
Q

Graft-vs-host disease

  • what is it
  • cause
  • two types
A

Multi-system complication of allogeneic BMT
T cells in the donor tissue mount an immune response towards the recipient’s cells
Severity is related to degree of HLA matching and number of donor T cells in the transplant

Acute GVHD: onset within 100 days of transplant, usually affects the skin, liver and GI tract, multi-system involvement carries worse prognosis

Chronic GVHD: may occur following acute disease, or arise on its own, >100 days after transplant, has a more varied clinical picture

96
Q

Acute GVHD features

A
Painful maculopapular rash, may progress to erythroderma or TEN
Jaundice
Watery or bloody diarrhoea
Persistent N+V
Culture-negative fever
97
Q

Chronic GVHD features

A

Poikiloderma, scleroderma, vitiligo, lichen planus
Keratoconjunctivitis sicca, corneal ulcers, scleritis
Dysphagia, odynophagia, oral ulcers, ileus
Obstructive or restrictive lung disease

Worse prognosis than acute

98
Q

Investigations for GVHD

A

LFTs
Abdo USS
Lung function tests
Biopsy of affected tissue

Often clinical diagnosis

99
Q

Management and prevention of GVHD

A

Mx: Immunosuppression and supportive measures
IV steroids, anti-TNF, etc

Prevention: prophylactic ciclosporin after transplantation (and/or MMF or methotrexate)

100
Q

Graft vs leukaemia effect

A

The T cells within the graft have been shown to have a direct anti-tumour effect on the recipients cells, aiding in treatment of the malignancy

However the T cells also increase the risk of GVHD

Balance the risk of GVL effect and GVHD